Sequential ctDNA whole-exome sequencing in advanced lung adenocarcinoma with initial durable tumor response on immune checkpoint inhibitor and late progression

BACKGROUND: Despite prolonged tumor response to immune checkpoint inhibitors (ICIs) for a subset of patients with advanced non-small cell lung cancer (NSCLC), a secondary resistance will occur for a majority of these patients. The understanding of late progression mechanisms with ICIs is important t...

Descripción completa

Detalles Bibliográficos
Autores principales: Giroux Leprieur, Etienne, Hélias-Rodzewicz, Zofia, Takam Kamga, Paul, Costantini, Adrien, Julie, Catherine, Corjon, Alexandre, Dumenil, Coraline, Dumoulin, Jennifer, Giraud, Violaine, Labrune, Sylvie, Garinet, Simon, Chinet, Thierry, Emile, Jean-François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319709/
https://www.ncbi.nlm.nih.gov/pubmed/32581058
http://dx.doi.org/10.1136/jitc-2020-000527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319709/
https://www.ncbi.nlm.nih.gov/pubmed/32581058
http://dx.doi.org/10.1136/jitc-2020-000527

Ejemplares similares